Muller HL. Childhood craniopharyngioma–current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol. 2010;6(11):609–18. https://doi.org/10.1038/nrendo.2010.168.

Article  PubMed  Google Scholar 

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89(4):547–51. https://doi.org/10.3171/jns.1998.89.4.0547.

Article  CAS  PubMed  Google Scholar 

Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN. Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro Oncol. 2012;14(8):1070–8. https://doi.org/10.1093/neuonc/nos142.

Article  PubMed  PubMed Central  Google Scholar 

De Alcubierre D, Gkasdaris G, Mordrel M, Joncour A, Briet C, Almairac F, et al. BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study. Eur J Endocrinol. 2024;191(2):251–61. https://doi.org/10.1093/ejendo/lvae091.

Article  PubMed  Google Scholar 

Gautier A, Godbout A, Grosheny C, Tejedor I, Coudert M, Courtillot C, et al. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab. 2012;97(4):1258–67. https://doi.org/10.1210/jc.2011-2817.

Article  CAS  PubMed  Google Scholar 

Pereira AM, Schmid EM, Schutte PJ, Voormolen JH, Biermasz NR, van Thiel SW, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf). 2005;62(2):197–204. https://doi.org/10.1111/j.1365-2265.2004.02196.x.

Article  PubMed  Google Scholar 

Visser J, Hukin J, Sargent M, Steinbok P, Goddard K, Fryer C. Late mortality in pediatric patients with craniopharyngioma. J Neurooncol. 2010;100(1):105–11. https://doi.org/10.1007/s11060-010-0145-5.

Article  PubMed  Google Scholar 

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen J, van der Lely AJ, et al. Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol. 2018;178(1):93–102. https://doi.org/10.1530/EJE-17-0707.

Article  CAS  PubMed  Google Scholar 

Wijnen M, van den Heuvel-Eibrink MM, Janssen J, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, et al. Very long-term sequelae of craniopharyngioma. Eur J Endocrinol. 2017;176(6):755–67. https://doi.org/10.1530/EJE-17-0044.

Article  CAS  PubMed  Google Scholar 

Muller HL. Craniopharyngioma. Endocr Rev. 2014;35(3):513–43. https://doi.org/10.1210/er.2013-1115.

Article  CAS  PubMed  Google Scholar 

Feola T, Pirchio RS, Puliani G, Pofi R, Crocco M, Sada V, et al. Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study. J Endocrinol Invest. 2023;46(1):181–8. https://doi.org/10.1007/s40618-022-01900-9.

Article  CAS  PubMed  Google Scholar 

Sbardella E, Puliani G, Feola T, Pofi R, Pirchio R, Sesti F, et al. A clinical approach to parasellar lesions in the transition age. J Neuroendocrinol. 2021;33(6):e12995. https://doi.org/10.1111/jne.12995.

Article  CAS  PubMed  Google Scholar 

Muller HL, Merchant TE, Puget S, Martinez-Barbera JP. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol. 2017;13(5):299–312. https://doi.org/10.1038/nrendo.2016.217.

Article  PubMed  Google Scholar 

Muller HL. Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary. 2017;20(2):267–81. https://doi.org/10.1007/s11102-016-0751-0.

Article  PubMed  Google Scholar 

Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C, et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab. 2013;98(6):2376–82. https://doi.org/10.1210/jc.2012-3928.

Article  CAS  PubMed  Google Scholar 

Qi S, Pan J, Lu Y, Gao F, Cao Y, Peng J, et al. The impact of the site of origin and rate of tumour growth on clinical outcome in children with craniopharyngiomas. Clin Endocrinol (Oxf). 2012;76(1):103–10. https://doi.org/10.1111/j.1365-2265.2011.04172.x.

Article  PubMed  Google Scholar 

Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen PK, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014;90(2):354–61. https://doi.org/10.1016/j.ijrobp.2014.05.051.

Article  PubMed  PubMed Central  Google Scholar 

Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, et al. 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 1993;27(2):189–95. https://doi.org/10.1016/0360-3016(93)90227-m.

Article  CAS  PubMed  Google Scholar 

Lee YY, Wong TT, Fang YT, Chang KP, Chen YW, Niu DM. Comparison of hypothalamopituitary axis dysfunction of intrasellar and third ventricular craniopharyngiomas in children. Brain Dev. 2008;30(3):189–94. https://doi.org/10.1016/j.braindev.2007.07.011.

Article  PubMed  Google Scholar 

Indelicato DJ, Bradley JA, Sandler ES, Aldana PR, Sapp A, Gains JE, et al. Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas. Pediatr Blood Cancer. 2017;64(12). https://doi.org/10.1002/pbc.26654.

Rombi B, Vennarini S, Vinante L, Ravanelli D, Amichetti M. Proton radiotherapy for pediatric tumors: review of first clinical results. Ital J Pediatr. 2014;40:74. https://doi.org/10.1186/s13052-014-0074-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bischoff M, Khalil DA, Frisch S, Backer CM, Peters S, Friedrich C, et al. Outcome after modern proton beam therapy in childhood craniopharyngioma: results of the prospective registry study KiProReg. Int J Radiat Oncol Biol Phys. 2024;120(1):137–48. https://doi.org/10.1016/j.ijrobp.2024.03.015.

Article  PubMed  Google Scholar 

Hussein Z, Glynn N, Martin N, Alkrekshi A, Mendoza N, Nair R, et al. Temporal trends in craniopharyngioma management and long-term endocrine outcomes: A multicentre cross-sectional study. Clin Endocrinol (Oxf). 2021;94(2):242–9. https://doi.org/10.1111/cen.14334.

Article  CAS  PubMed  Google Scholar 

Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al-Ashwal A. Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab. 2001;14(7):869–74. https://doi.org/10.1515/jpem.2001.14.7.869.

Article  CAS  PubMed  Google Scholar 

Ferrau F, Spagnolo F, Cotta OR, Cannavo L, Alibrandi A, Russo GT, et al. Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma. Endocrine. 2017;58(2):295–302. https://doi.org/10.1007/s12020-016-1196-y.

Article  CAS  PubMed  Google Scholar 

Gonc EN, Yordam N, Ozon A, Alikasifoglu A, Kandemir N. Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases. Pediatr Neurosurg. 2004;40(3):112–9. https://doi.org/10.1159/000079852.

Article  PubMed  Google Scholar 

Holmer H, Ekman B, Bjork J, Nordstom CH, Popovic V, Siversson A, et al. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. Eur J Endocrinol. 2009;161(5):671–9. https://doi.org/10.1530/EJE-09-0449.

Article  CAS  PubMed  Google Scholar 

Huang CC, Lin KL, Wu CT, Jung SM, Wang CJ, Chen YC, et al. Clinical and endocrinological manifestations of childhood-onset craniopharyngioma before surgical removal: a report from one medical center in Taiwan. Pediatr Neonatol. 2021;62(2):181–6. https://doi.org/10.1016/j.pedneo.2020.08.014.

Article  PubMed  Google Scholar 

Jung HW, Kim HY, Kim JY, Cheon JE, Kim IO, Kim SK, et al. Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma. PLoS ONE. 2021;16(2):e0246789. https://doi.org/10.1371/journal.pone.0246789.

Article  CAS  PubMed  PubMed Central